Han et al. demonstrated that high expression of miR-1307-3p, which targets SMYD4, is associated with poor prognosis in breast cancer patients, indicating that miR-1307-3p potentially plays an oncogenic role by downregulating SMYD4 expression107. Here, SMYD4 is linked to breast carcinoma.